Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

CHMP recommends eight new medicines for EU approval

CHMP recommends eight new medicines for EU approval

BMS’ CAR T therapy Abecma and BioMarin’s dwarfism drug Voxzogo among positive recommendations. ... Next up is BioMarin’s Voxzogo (vosoritide), which has been recommended for the treatment of achondroplasia in patients aged two years and above whose

Keeping up with the developing regulatory requirements for gene and cell therapies

Keeping up with the developing regulatory requirements for gene and cell therapies The FDA’s requirement on Biomarin to provide an additional two years of clinical data of Valrox before approval signals an increase in regulatory scrutiny for the regenerative medicine industry. ... That’s why developers have started exploring other

Sourcing R&D innovation: why pharma companies need to evolve their business models

Sourcing R&D innovation: why pharma companies need to evolve their business models including Shire/Takeda, Actelion/J&J, Sanofi Genzyme, Alexion, Amicus, BioMarin, Sarepta and Vertex.

The best work in healthcare communications shines at virtual Communiqué Awards

The best work in healthcare communications shines at virtual Communiqué Awards Winner: Dementia Strikes Children Too: Collaborative Campaigning for Access by Portland for BioMarin.

Learning Lessons on Lung Cancer: Driving Change Across the UK

Sponsored by. by Portland for BioMarin. ... Dementia Strikes Children Too: Collaborative Campaigning for Access - by Portland for BioMarin.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...